Full-Time

Senior Scientist

Cmo Msat

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Senior

Bridgewater Township, NJ, USA

Hybrid work model; requires some in-office presence.

Category
Biology Lab & Research
Biology & Biotech

You match the following Legend Biotech's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • B.S. or more advanced degree is required, Ph. D is preferred, in related technical disciplines: engineering, biological science, pharmaceutical science etc.
  • Minimum 5 years for BS/MS, 3 years for PhD of industrial biologics CMC development or manufacturing experience, Cell therapy manufacture experience is highly desirable.
  • Experience working with CMO is a preferred.
  • Results driven with strong analytical, problem solving and critical thinking skills.
  • Experience in a fast-paced and dynamic environment.
  • Excellent time-management, organizational and communication skills.
  • Strong business acumen and change management experience.
Responsibilities
  • Manage and oversee all technical side of the CMO activities: deviation investigation, change control and risk assessment, process improvement, continuous process validation.
  • Support commercial and developmental batches as a technical PIP as needed.
  • Provide timely and accurate update on the timeline, status of the projects, risk and mitigation strategy to the manager and cross functional stakeholders.
  • Monitor manufacture performance. Identify, investigate and act upon out-of-trend critical process parameters (CPP) in-process testing and CQAs.
  • Work with the global MSAT team on global change control and process improvement.
Desired Qualifications
  • Experience working with CMO is a preferred.

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
  • New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
  • Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

What critics are saying

  • Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
  • Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
  • Financial strain from new R&D facility could affect operational focus if advancements lag.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
  • Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options